The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,176.00
Bid: 1,170.00
Ask: 1,185.00
Change: -78.00 (-6.22%)
Spread: 15.00 (1.282%)
Open: 1,290.00
High: 1,290.00
Low: 1,148.00
Prev. Close: 1,254.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Burford Raises £100m in Bonds to reach US$1bn mark

19 Apr 2016 14:02

RNS Number : 6736V
Burford Capital
19 April 2016
 

19 April 2016

 

 

BURFORD CAPITAL RAISES £100 MILLION IN BOND ISSUE

TO REACH BILLION DOLLAR MARK IN LITIGATION FINANCE

 

Burford Capital Limited ("Burford"), a leading global finance firm focused on law, announces that it has today raised a further £100 million (approximately $144 million) through an oversubscribed issue of bonds on the Main Market of the London Stock Exchange by Burford Capital PLC, its UK financing subsidiary. The bonds will pay interest at an annual rate of 6.125% and mature on 26 October 2024.

 

Combined with Burford's prior investment commitments, this new capital once deployed will take Burford's cumulative litigation finance investment commitments to approximately $1 billion. Burford's portfolio today is large and widely diversified, with more than 500 individual litigation matters underlying its investments for clients from around the world. Burford continues to see strong demand from law firms and corporate clients for its capital and professional services.

 

Christopher Bogart, Burford's Chief Executive Officer, commented:

"We are very pleased with the strong response to our second bond issue, which at £100 million has well exceeded our first issue and continues to provide us with an unmatched capital base. The legal sector is rapidly evolving alternative economic models and demand is increasing globally for Burford's services. The use of external capital by law firms to support their growth is accelerating, even as corporate clients seek new ways to manage ongoing costs and monetize litigation assets.

 

"We are grateful for the continuing support of our investors in both our bonds, which has permitted this further expansion of our business, and our shares. We look forward to demonstrating Burford's further potential."

 

 

The bonds have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered and sold in the United States absent registration or an applicable exemption from registration.

 

 

For further information, please contact:

 

Canaccord Genuity Limited (Joint Lead Manager on the Bond)

+44 (0) 20 7523 8000

Adrian Bell

Mark Glowrey

Henrietta Podd

Peel Hunt LLP  (Joint Lead Manager on the Bond)

+44 (0) 20 7418 8900

Matthew Armitt

Kathy Boate

Macquarie Capital (Europe) Limited (Nomad)

+44 (0)20 3037 2000

Ken Fleming

Nicholas Harland

Neustria Partners - Financial Communications for Burford Capital

+44 (0)20 3021 2580

Robert Bailhache

robert.bailhache@neustriapartners.com

 

 

About Burford Capital

 

Burford is a leading global finance firm focused on law. Our businesses include litigation finance, insurance and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. Burford's equity and debt securities are publicly traded on the London Stock Exchange. We work with lawyers and clients around the world from our principal offices in New York and London.

 

For more information about Burford, visit www.burfordcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODXKLFFQZFBBBF
Date   Source Headline
13th May 202412:00 pmRNS1Q24 Results & Quarterly Report
9th May 20247:00 amRNSNotice of 1Q24 Results & Results Call Details
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.